• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国胃肠病学会关于2019冠状病毒病大流行期间炎症性肠病管理的临床实践更新:专家评论

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

作者信息

Rubin David T, Feuerstein Joseph D, Wang Andrew Y, Cohen Russell D

机构信息

Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois.

Division of Gastroenterology and Center for Inflammatory Bowel Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

出版信息

Gastroenterology. 2020 Jul;159(1):350-357. doi: 10.1053/j.gastro.2020.04.012. Epub 2020 Apr 10.

DOI:10.1053/j.gastro.2020.04.012
PMID:32283100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7151253/
Abstract

The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update was to rapidly review the emerging evidence and provide timely expert recommendations regarding the management of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely perspective on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology.

摘要

美国胃肠病学会(AGA)研究所临床实践更新的目的是迅速回顾新出现的证据,并就2019冠状病毒病大流行期间炎症性肠病患者的管理提供及时的专家建议。本专家评论由AGA研究所临床实践更新委员会和AGA理事会委托并批准,旨在就一个对AGA会员具有高度临床重要性的主题提供及时的观点,并经过临床实践更新委员会的内部同行评审以及通过《胃肠病学》的标准程序进行外部同行评审。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3b/7151253/c7acd1c99455/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3b/7151253/c7acd1c99455/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a3b/7151253/c7acd1c99455/gr1_lrg.jpg

相似文献

1
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.美国胃肠病学会关于2019冠状病毒病大流行期间炎症性肠病管理的临床实践更新:专家评论
Gastroenterology. 2020 Jul;159(1):350-357. doi: 10.1053/j.gastro.2020.04.012. Epub 2020 Apr 10.
2
Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.冠状病毒与炎症性肠病患者:临床医生的管理策略
Am J Gastroenterol. 2020 Oct;115(10):1566-1569. doi: 10.14309/ajg.0000000000000817.
3
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy.美国胃肠病学会关于术前新型冠状病毒2检测与内镜检查作用的快速回顾及建议
Gastroenterology. 2020 Nov;159(5):1935-1948.e5. doi: 10.1053/j.gastro.2020.07.043. Epub 2020 Jul 28.
4
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.COVID-19 大流行期间炎症性肠病患者的实用管理:澳大利亚胃肠病学会炎症性肠病学院专家评论。
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
5
Strategies and recommendations for the safe implementation of vascular surgery during the pandemic period of novel coronavirus pneumonia.新型冠状病毒肺炎大流行期间血管手术安全实施的策略与建议
J Vasc Surg. 2020 Jul;72(1):377-378. doi: 10.1016/j.jvs.2020.04.466. Epub 2020 Apr 22.
6
Endoscopy works during the pandemic of coronavirus COVID-19: recommendations by the Chinese Society of Digestive Endoscopy.在冠状病毒 COVID-19 大流行期间,内镜检查仍然适用:中国消化内镜学会的建议。
United European Gastroenterol J. 2020 Aug;8(7):798-803. doi: 10.1177/2050640620930632. Epub 2020 Jul 2.
7
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
United European Gastroenterol J. 2020 Aug;8(7):775-781. doi: 10.1177/2050640620929133. Epub 2020 May 21.
8
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.AGA 临床实践更新:炎症性肠病患者的饮食和营养治疗:专家综述。
Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23.
9
AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.美国胃肠病学会关于2019冠状病毒病大流行期间胃肠道手术的快速建议
Gastroenterology. 2020 Aug;159(2):739-758.e4. doi: 10.1053/j.gastro.2020.03.072. Epub 2020 Apr 1.
10
Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic.关于2019冠状病毒病大流行期间皮肤癌管理建议的观点
J Am Acad Dermatol. 2020 Jul;83(1):295-296. doi: 10.1016/j.jaad.2020.05.002. Epub 2020 May 6.

引用本文的文献

1
2019 Novel Coronavirus Infection: Gastrointestinal Manifestations.2019新型冠状病毒感染:胃肠道表现
J Dig Endosc. 2020 Mar;11(1):13-18. doi: 10.1055/s-0040-1712077. Epub 2020 May 16.
2
Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission.处于临床缓解期的免疫介导疾病患者从静脉注射英夫利昔单抗转换为皮下注射英夫利昔单抗。
Front Med (Lausanne). 2025 May 16;12:1583401. doi: 10.3389/fmed.2025.1583401. eCollection 2025.
3
The Challenges in Treating Inflammatory Bowel Diseases During the COVID-19 Pandemic: An Opinion.

本文引用的文献

1
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征:一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
2
Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.2019冠状病毒病大流行期间克罗恩病和溃疡性结肠炎患者的管理:一次国际会议的结果
Gastroenterology. 2020 Jul;159(1):6-13.e6. doi: 10.1053/j.gastro.2020.04.002. Epub 2020 Apr 6.
3
新冠疫情期间炎症性肠病的治疗挑战:一种观点
J Clin Med. 2024 Nov 25;13(23):7128. doi: 10.3390/jcm13237128.
4
Navigating SARS-CoV-2-related immunopathology in Crohn's disease: from molecular mechanisms to therapeutic challenges.探讨克罗恩病中与 SARS-CoV-2 相关免疫病理学:从分子机制到治疗挑战。
Virol J. 2024 Nov 13;21(1):288. doi: 10.1186/s12985-024-02529-1.
5
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center.免疫介导的炎症性疾病患者中 COVID-19 的症状与严重程度:一所大学医学中心的经验
Autoimmune Dis. 2024 Mar 27;2024:6627035. doi: 10.1155/2024/6627035. eCollection 2024.
6
Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease.COVID-19 治疗对炎症性肠病真实世界结局的影响。
Dig Dis Sci. 2024 May;69(5):1654-1660. doi: 10.1007/s10620-024-08355-3. Epub 2024 Mar 11.
7
Exploring the Impact of COVID-19 on Ulcerative Colitis Patients: A Lifestyle Perspective.从生活方式角度探讨新冠病毒病对溃疡性结肠炎患者的影响
Medicina (Kaunas). 2024 Jan 20;60(1):182. doi: 10.3390/medicina60010182.
8
The effectiveness of continuity of care in patients with inflammatory bowel disease: a systematic review.炎症性肠病患者连续性护理的效果:系统评价。
BMC Gastroenterol. 2024 Jan 8;24(1):24. doi: 10.1186/s12876-023-03109-3.
9
COVID-19 Outcomes in Inflammatory Bowel Disease Hospitalized Patients: A Comprehensive Analysis Using the National Inpatient Sample.炎症性肠病住院患者的COVID-19结局:使用全国住院患者样本的综合分析
Gastroenterology Res. 2023 Oct;16(5):262-269. doi: 10.14740/gr1657. Epub 2023 Oct 21.
10
Impact of the COVID-19 Pandemic on the Lifestyle and Psychosocial Behavior of Patients with Inflammatory Bowel Diseases: A Narrative Review.2019年冠状病毒病大流行对炎症性肠病患者生活方式和心理社会行为的影响:一项叙述性综述
Healthcare (Basel). 2023 Sep 28;11(19):2642. doi: 10.3390/healthcare11192642.
AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.
美国胃肠病学会关于2019冠状病毒病大流行期间胃肠道手术的快速建议
Gastroenterology. 2020 Aug;159(2):739-758.e4. doi: 10.1053/j.gastro.2020.03.072. Epub 2020 Apr 1.
4
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
5
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病(COVID-19)患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
6
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
7
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1(SARS-CoV-1)相比,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在气溶胶和表面的稳定性
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
8
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
9
Unveiling the Origin and Transmission of 2019-nCoV.揭开 2019-nCoV 的起源与传播之谜。
Trends Microbiol. 2020 Apr;28(4):239-240. doi: 10.1016/j.tim.2020.02.001. Epub 2020 Feb 24.
10
Evidence for Gastrointestinal Infection of SARS-CoV-2.新型冠状病毒2019(SARS-CoV-2)胃肠道感染的证据。
Gastroenterology. 2020 May;158(6):1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055. Epub 2020 Mar 3.